CVI Holdings’s IDEAYA Biosciences IDYA Stock Holding History

CVI Holdings’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,097	Closed	-$158K	–	99
2020 Q2	$158K	Buy	+11,097	New	+$87.4K	0.06%	55

Other funds holding IDYA

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

CVI Holdings's IDYA Position: Q3 2020 in Review

CVI Holdings sold out of IDEAYA Biosciences (IDYA) in Q3 2020, closing a stake of 11,097 shares — an estimated $158K sold.

CVI Holdings first reported a position in IDYA in Q2 2020 and held it in 1 quarter. The position peaked at $158K in Q2 2020. 68 funds tracked by Wall St. Rank hold IDYA as of Q3 2020.

CVI Holdings reported no remaining IDEAYA Biosciences position as of Q3 2020 after selling out during the quarter.
CVI Holdings sold 11,097 IDEAYA Biosciences shares in Q3 2020, an estimated $158K.
CVI Holdings first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 1 quarter.
CVI Holdings's IDEAYA Biosciences position peaked at $158K in Q2 2020.
68 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2020.

Based on CVI Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.